Editor‐in‐Chief
Michel Drancourt, MD, PhD
Aix‐Marseille University, France
Editorial Board
Jônatas Santos Abrahão
Federal University of Minas Gerais, Brazil
Wuguo Chen
University of North Carolina at Chapel Hill, USA
François Denis
University of Limoges, France
Tahar Kernif
Institut Pasteur d'Algérie, Algeria
Xavier de Lamballerie
Marseille Medical University, France
Vu Dang La
University of Pennsylvania, USA
Míriam‐José Álvarez Martínez
University of Barcelona, Spain
Doumbo Ogobara
Université des sciences, Techniques & Technologies, Mali
Wanderley de Souza
Brazilian Academy of Sciences, Brazil
Oleg Mediannikov
Campus Commun UCAD‐IRD d'Hann, Senegal
Ruifu Yang
Beijing Institute of Microbiology and Epidemiology, China
Aims and Scope
New Microbes and New Infections is an official publication of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). It serves the field as a peer‐reviewed, open access journal for rapid dissemination of the latest research, with a particular focus on new genomes, new microbes, and new technology applied to the diagnosis of infectious/tropical diseases.
Article categories include first descriptions of a microbe in a country, first descriptions of resistance in a country, first case reports in a country and minireviews, as well as full length original articles. New Microbes and New Infections offers clinicians and researchers a rapid route to publication and the opportunity to publish in a highly visible global forum. The journal draws on the same expert panel of reviewers as Clinical Microbiology and Infection (CMI).
This new journal's emphasis on concise reports on specific topics distinguishes it from Clinical Microbiology and Infection, which will continue to publish manuscripts presenting basic and applied research in the fields of microbiology, infectious diseases, virology, parasitology, immunology and epidemiology.
The open access format of New Microbes and New Infections ensures that accepted manuscripts will be rapidly published and fully accessible by interested professionals worldwide. For further information visit the Wiley Open Access website at http://www.wileyopenaccess.com.
Open Access and Copyright
All New Microbes and New Infections articles are published under a Creative Commons License. All Research Councils UK (RCUK) and Wellcome Trust funded authors will be directed to the Creative Commons Attribution license (CC BY) in accordance with funder mandates effective on 1 April 2013. All other authors (non‐RCUK and Wellcome Trust authors) will be free to choose from the Creative Commons Attribution Non‐Commercial (CC BY NC), and the Attribution‐Non‐Commercial‐NoDerivs (CC BY NC ND).
Copyright on any research article in a journal published by New Microbes and New Infections is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Further information about open access license and copyright can be found at http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright‐‐License.html.
Purchasing Print Reprints
Print reprints of Wiley Open Access articles can be purchased from corporatesales@wiley.com.
Disclaimer
The Publisher and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily reflect those of the Publisher and Editors, neither does the publication of advertisements constitute any endorsements by the Publisher and Editors of the products advertised.
Wiley Open Access articles posted to repositories or websites are without warranty from Wiley of any kind, either express or implied, including, but not limited to, warranties of merchantability, fitness for a particular purpose, or non‐infringement. To the fullest extent permitted by law Wiley disclaims all liability for any loss or damage arising out of, or in connection with, the use of or inability to use the content.